Hidefumi Kasai

545 total citations
37 papers, 350 citations indexed

About

Hidefumi Kasai is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Hidefumi Kasai has authored 37 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 9 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Hidefumi Kasai's work include Antibiotics Pharmacokinetics and Efficacy (16 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Hidefumi Kasai is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (16 papers), Antimicrobial Resistance in Staphylococcus (7 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Hidefumi Kasai collaborates with scholars based in Japan, United States and New Zealand. Hidefumi Kasai's co-authors include Yasuhiro Tsuji, Hideto To, Yoshihiro Yamamoto, Yusuke Tanigawara, Chika Ogami, Akiko Mizoguchi, Young‐A Heo, Nicholas H. G. Holford, Yoichi Hiraki and Takeshi Yamashita and has published in prestigious journals such as Frontiers in Microbiology, Journal of Pharmaceutical Sciences and Osteoporosis International.

In The Last Decade

Hidefumi Kasai

36 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidefumi Kasai Japan 12 154 145 56 54 47 37 350
Serena Fucile Italy 9 219 1.4× 78 0.5× 47 0.8× 31 0.6× 31 0.7× 15 366
Amirhooshang Mohammadpour Iran 7 205 1.3× 175 1.2× 64 1.1× 80 1.5× 43 0.9× 11 416
David T. Rock United States 5 148 1.0× 165 1.1× 55 1.0× 47 0.9× 27 0.6× 6 302
Julia Tonini France 11 186 1.2× 76 0.5× 135 2.4× 13 0.2× 34 0.7× 20 348
Chika Ogami Japan 10 165 1.1× 156 1.1× 46 0.8× 69 1.3× 31 0.7× 18 306
William Knebel United States 11 280 1.8× 233 1.6× 161 2.9× 58 1.1× 28 0.6× 20 504
Yoke Lin Lo Malaysia 12 139 0.9× 214 1.5× 79 1.4× 32 0.6× 17 0.4× 33 493
Melisa Cooper United Kingdom 12 55 0.4× 270 1.9× 166 3.0× 38 0.7× 73 1.6× 20 583
Wen Gao China 15 51 0.3× 55 0.4× 121 2.2× 21 0.4× 66 1.4× 35 609
Min Cui China 9 88 0.6× 49 0.3× 40 0.7× 6 0.1× 89 1.9× 20 319

Countries citing papers authored by Hidefumi Kasai

Since Specialization
Citations

This map shows the geographic impact of Hidefumi Kasai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidefumi Kasai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidefumi Kasai more than expected).

Fields of papers citing papers by Hidefumi Kasai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidefumi Kasai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidefumi Kasai. The network helps show where Hidefumi Kasai may publish in the future.

Co-authorship network of co-authors of Hidefumi Kasai

This figure shows the co-authorship network connecting the top 25 collaborators of Hidefumi Kasai. A scholar is included among the top collaborators of Hidefumi Kasai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidefumi Kasai. Hidefumi Kasai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Tsuji, Yasuhiro, Nicholas H. G. Holford, Chika Ogami, et al.. (2023). Population Pharmacokinetic Model for Unbound Concentrations of Daptomycin in Patients with MRSA Including Patients Undergoing Hemodialysis. European Journal of Drug Metabolism and Pharmacokinetics. 48(2). 201–211. 1 indexed citations
4.
5.
Tsuji, Yasuhiro, Hidefumi Kasai, Chika Ogami, et al.. (2021). Classification Tree Analysis Based On Machine Learning for Predicting Linezolid-Induced Thrombocytopenia. Journal of Pharmaceutical Sciences. 110(5). 2295–2300. 8 indexed citations
6.
Tsushima, Takahiro, Hidefumi Kasai, & Yusuke Tanigawara. (2020). Pharmacokinetic and pharmacodynamic analysis of neutropenia following nab-paclitaxel administration in Japanese patients with metastatic solid cancer. Cancer Chemotherapy and Pharmacology. 86(4). 487–495. 3 indexed citations
8.
Kawamura, Takahisa, et al.. (2018). Pharmacodynamic analysis of eribulin safety in breast cancer patients using real‐world postmarketing surveillance data. Cancer Science. 109(9). 2822–2829. 6 indexed citations
9.
Tsuji, Yasuhiro, et al.. (2018). Population Pharmacokinetics and Exposure–Response of Lithium Carbonate in Patients Based on Tubular Reabsorption Mechanisms. European Journal of Drug Metabolism and Pharmacokinetics. 44(3). 329–338. 3 indexed citations
10.
Suzuki, Shinya, Takeshi Yamashita, Hidefumi Kasai, Takayuki Otsuka, & Koichi Sagara. (2018). An analysis on distribution and inter-relationships of biomarkers under rivaroxaban in Japanese patients with non-valvular atrial fibrillation (CVI ARO 1). Drug Metabolism and Pharmacokinetics. 33(4). 188–193. 18 indexed citations
11.
Okada, Akira, Hidetaka Ushigome, Hidefumi Kasai, et al.. (2017). Population pharmacokinetics of cyclosporine A in Japanese renal transplant patients: comprehensive analysis in a single center. European Journal of Clinical Pharmacology. 73(9). 1111–1119. 12 indexed citations
12.
Ogami, Chika, Yasuhiro Tsuji, Hidefumi Kasai, et al.. (2017). Evaluation of pharmacokinetics and the stability of daptomycin in serum at various temperatures. International Journal of Infectious Diseases. 57. 38–43. 13 indexed citations
13.
Kasai, Hidefumi, et al.. (2017). Population pharmacokinetics of teicoplanin in hospitalized elderly patients using cystatin C as an indicator of renal function. Journal of Infection and Chemotherapy. 24(4). 284–291. 20 indexed citations
14.
Kunisawa, Takayuki, Hidefumi Kasai, Manabu Yoshimura, et al.. (2014). Population pharmacokinetics of olprinone in healthy male volunteers. Clinical Pharmacology Advances and Applications. 6. 43–43. 1 indexed citations
15.
Kasai, Hidefumi, et al.. (2012). Population pharmacokinetics of phenytoin after intravenous administration of fosphenytoin sodium in pediatric patients, adult patients, and healthy volunteers. European Journal of Clinical Pharmacology. 69(3). 489–97. 17 indexed citations
16.
Hagihara, Mao, Takahiro Kato, Takaaki Hasegawa, et al.. (2010). Pharmacokinetic–pharmacodynamic study of itraconazole in patients with fungal infections in intensive care units. Journal of Infection and Chemotherapy. 17(2). 224–230. 8 indexed citations
17.
Kasai, Hidefumi, Yoshitaka Hashimoto, Tomoya Ohno, et al.. (2008). Population Pharmacokinetics of Landiolol Hydrochloride in Healthy Subjects. Drug Metabolism and Pharmacokinetics. 23(6). 447–455. 12 indexed citations
18.
Kasai, Hidefumi, Kazuaki Kawai, N. Yamada, et al.. (2007). Changes of Urinary 8-Hydroxydeoxyguanosine Levels during a Two-Day Ultramarathon Race Period in Japanese Non-Professional Runners. International Journal of Sports Medicine. 29(1). 27–33. 29 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026